Total syntheses of ent-conduramine A and ent-7-deoxypancratistatin

Tetrahedron Letters

Volumn 40, Issue 16, 1999, Pages 3081-3084

  Akgün, Hülya ^a,b   Hudlicky, Tomas ^a  

^a University of Florida ^*  (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEOXYPANCRATISTATIN; ALKALOID; CONDURAMINE A; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; ENANTIOMER; REACTION ANALYSIS;

EID: 0033574720     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00434-7     Document Type: Article

References (37)

1. Tian, X.; Hudlicky, T.; Konigsberger, K. J. Am. Chem. Soc. 1995, 117, 3643;
2. (b) Trost, B. M.; Pulley, S. R. J. Am. Chem. Soc. 1995, 117, 10143;
3. (c) Doyle, T. J.; Hendrix, M.; Vanderveer, D.; Javanmard, S.; Haseltine, J. Tetrahedron 1997, 53, 11153;
4. (d) Magnus, P.; Sebhat, I. K. J. Am. Chem. Soc. 1998, 120, 5341; Tetrahedron, 1998, 54, 15509, and references within;
5. (d) Magnus, P.; Sebhat, I. K. J. Am. Chem. Soc. 1998, 120, 5341; Tetrahedron, 1998, 54, 15509, and references within;
6. (e) First synthesis (racemic): Danishefsky, S.; Lee, J. Y. J. Am. Chem. Soc. 1989, 111, 4829.
7. For references to the synthesis of 7-deoxypancratistatin see: (f) Tian, X.; Maurya, R.; Konigsberger, K.; Hudlicky, T. Synlett 1995, 1125;
8. (g) Hudlicky, T.; Tian, X.; Konigsberger, K.; Maurya, R.; Rouden, J.; Fan, B. J. Am. Chem. Soc. 1996, 118, 10752;
9. (h) Keck, G. E.; McHardy, S. F.; Murry, J. A. J. Am. Chem. Soc. 1995, 117, 7289;
10. (i) Chida, N.; Jitsuoka, M.; Yamamoto, Y.; Ohtsuka, M.; Ogawa, S. Heterocycles 1996, 43, 1385;
11. (j) Keck, G. E.; Wager, T. T.; McHardy, S. F. J. Org. Chem. 1998, 63, 9164.
12. Keck, G. E.; Wager, T. T. J. Org. Chem. 1996, 61, 8366.
13. Rigby, J. H.; Mateo, M. E. J. Am. Chem. Soc. 1997, 119, 12655;
14. (b) For the second asymmetric synthesis see: Keck, G. E.; Wager, T. T.; Rodriguez, F.; 216th. ACS National Meeting, 1998, Boston;
15. (c) Hudlicky, T.; Gonzalez, D.; Martinot, T. Tetrahedron Lett. 1999, 40, 3077.
16. Polt. R. in Organic Synthesis: Theory and Applications, Hudlicky, T., Ed.; JAI press, 1997; Vol. 3., p. 109.
17. For references to biological activities of these alkaloids see for example: (pancratistatin and 7-deoxypancratistatin) (a) Abou-Donia, A. H.; De Giulio, A.; Evidente, A.; Gaber, M.; Habib, A. A.; Lanzetta, R.; Seif El Din, A. Phytochemistry 1991, 30, 3445;
18. (b) Pettit, G. R.; Gaddamidi, V.; Herald, D. L.; Singh, S. B.; Cragg, G. M.; Schmidt, J. M.; Boettner, F. E.; Williams, M.; Sagawa, Y. J. Nat. Prod. 1986, 49, 995;
19. (c) (lycoricidine) Okamoto, T.; Torii, Y.; Isogai, Y. Chem. Pharm. Bull. 1968, 16, 1860;
20. (d) (narciclasine) Ceriotti, G. Nature 1967, 11, 595;
21. (e) Hudlicky, T.; Pettit, G. R., unpublished observations: Deoxypancratistatin, ent-deoxypancratistatin, and several truncated derivatives have been tested by the Pettit group against human cancer cell lines. The full details of the biological profiles will be published in an upcoming full account.
22. Allen, C. C. R.; Boyd, D. R.; Dalton, H.; Sharma, N. D.; Brannigan, I.; Kerley, N. A.; Sheldrake, G. N.; Taylor, S. C. J. Chem. Soc., Chem. Commun. 1995, 117.
23. Hudlicky, T.; Price, J. D.; Rulin, F.; Tsunoda, T. J. Am. Chem. Soc. 1990, 772, 9439.
24. Hudlicky, T.; Olivo, H. F.; McKibben, B. J. Am. Chem. Soc. 1994, 116, 5108.
25. Johnson, C. R.; Adams, J. P.; Collins, M. A. J. Chem. Soc., Perkin Trans. 1, 1993, 1.
26. Olivo, H. F.; Hemenway, M. S.; Hartwig, A. C. Chan, R. Synlett, 1998, 247.
27. For previous syntheses of aziridines of type 2 see reference 1(f), and bibliography cited therein.
28. Banwell, M. G.; Bissett, B. D.; Busato, S.; Cowden, C. J.; Hockless, D. C. R.; Holman, J. W.; Read, R. W.; Wu, A. W. J. Chem. Soc., Chem. Commun. 1995, 2551.
29. Carless, H. A. J.; Oak, O. Z. J. Chem. Soc., Chem. Commun. 1991, 61.
30. Keck, G. E.; Fleming, S.; Nickell, D.; Weider, P. Synth. Commun. 1979, 9, 281.
31. Ritter, A. R.; Miller, M. J. J. Org. Chem. 1994, 59, 4602.
32. For references on the use of microbial dioxygenases please consult: (a) Gibson, D. T.; Hensley, M.; Yoshioka, H.; Mabry, T.J. Biochemistry 1970, 9, 1626;
33. (b) Zylstra, G. J.; Gibson, D. T. J. Biol. Chem. 1989, 264, 14940.
34. For recent reviews on the applications of cyclohexadiene cis-diols in enantioselective synthesis see: (a) Boyd, D. R.; Sheldrake, G. N. Nat. Prod. Reports 1998, 15, 309; Hudlicky, T.; Thorpe, A. J. J.chem. Soc., Chem. Commun. 1996, 1993; Hudlicky, T.; Gonzalez, D.; Gibson, D. T. Aldrichimicaacta 1999, in press.
35. For recent reviews on the applications of cyclohexadiene cis-diols in enantioselective synthesis see: (a)Boyd, D. R.; Sheldrake, G. N. Nat. Prod. Reports 1998, 15, 309; Hudlicky, T.; Thorpe, A. J. J. Chem. Soc., Chem. Commun. 1996, 1993; Hudlicky, T.; Gonzalez, D.; Gibson, D. T. Aldrichimicaacta 1999, in press.
36. For recent reviews on the applications of cyclohexadiene cis-diols in enantioselective synthesis see: (a)Boyd, D. R.; Sheldrake, G. N. Nat. Prod. Reports 1998, 15, 309; Hudlicky, T.; Thorpe, A. J. J.chem. Soc., Chem. Commun. 1996, 1993; Hudlicky, T.; Gonzalez, D.; Gibson, D. T. Aldrichimica Acta 1999, in press.
37. Analytical and spectral data obtained were consistent with the structural assignments of all compounds.